SG11202000695RA - Method for virus filtration of von willebrand factor - Google Patents

Method for virus filtration of von willebrand factor

Info

Publication number
SG11202000695RA
SG11202000695RA SG11202000695RA SG11202000695RA SG11202000695RA SG 11202000695R A SG11202000695R A SG 11202000695RA SG 11202000695R A SG11202000695R A SG 11202000695RA SG 11202000695R A SG11202000695R A SG 11202000695RA SG 11202000695R A SG11202000695R A SG 11202000695RA
Authority
SG
Singapore
Prior art keywords
von willebrand
willebrand factor
virus filtration
virus
filtration
Prior art date
Application number
SG11202000695RA
Inventor
Thomas Nowak
Holger Lind
Original Assignee
Csl Behring Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Csl Behring Gmbh filed Critical Csl Behring Gmbh
Publication of SG11202000695RA publication Critical patent/SG11202000695RA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/34—Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/37—Factors VIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A61L2/0017—Filtration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
    • A61L2/04—Heat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
    • A61L2/08—Radiation
    • A61L2/081—Gamma radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
    • A61L2/08—Radiation
    • A61L2/084—Visible light
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
    • A61L2/08—Radiation
    • A61L2/10—Ultraviolet radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2202/00—Aspects relating to methods or apparatus for disinfecting or sterilising materials or objects
    • A61L2202/20—Targets to be treated
    • A61L2202/21—Pharmaceuticals, e.g. medicaments, artificial body parts

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Water Supply & Treatment (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SG11202000695RA 2017-08-23 2018-08-23 Method for virus filtration of von willebrand factor SG11202000695RA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP17187436 2017-08-23
PCT/EP2018/072710 WO2019038350A1 (en) 2017-08-23 2018-08-23 Method for virus filtration of von willebrand factor

Publications (1)

Publication Number Publication Date
SG11202000695RA true SG11202000695RA (en) 2020-03-30

Family

ID=59713839

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202000695RA SG11202000695RA (en) 2017-08-23 2018-08-23 Method for virus filtration of von willebrand factor

Country Status (10)

Country Link
US (1) US20200199176A1 (en)
EP (1) EP3672644A1 (en)
JP (1) JP2020531516A (en)
KR (1) KR20200038309A (en)
CN (1) CN110997015A (en)
AU (1) AU2018321131A1 (en)
BR (1) BR112020002234A2 (en)
CA (1) CA3072003A1 (en)
SG (1) SG11202000695RA (en)
WO (1) WO2019038350A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4103167A4 (en) * 2020-02-14 2024-03-13 Tranexamic Tech Llc Methods and compositions for antimicrobial use of synthetic lysine analogs, derivatives, mimetics, and prodrugs

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4751180A (en) 1985-03-28 1988-06-14 Chiron Corporation Expression using fused genes providing for protein product
US4935233A (en) 1985-12-02 1990-06-19 G. D. Searle And Company Covalently linked polypeptide cell modulators
US5110907A (en) 1989-08-01 1992-05-05 Alpha Therapeutic Corporation Factor viii complex purification using heparin affinity chromatography
US5288853A (en) 1992-04-30 1994-02-22 Alpha Therapeutic Corporation Factor viii purification process
DE4435485C1 (en) 1994-10-04 1996-03-21 Immuno Ag Process for obtaining high-purity von Willebrand factor
FR2772381B1 (en) * 1997-12-15 2001-06-08 Lab Francais Du Fractionnement PROCESS FOR THE PREPARATION BY FILTRATION OF A VIRALLY SECURE FACTOR VIII SOLUTION
AU6277799A (en) * 1998-10-02 2000-04-26 Eli Lilly And Company Il-17 homolog nucleic acids, polypeptides, vectors, host cells, methods and usesthereof
KR20020063597A (en) * 1999-12-20 2002-08-03 미츠비시 웰파마 가부시키가이샤 Virus-free plasma protein compositions treated with porous membrane and process for producing the same
DE10022092A1 (en) * 2000-05-08 2001-11-15 Aventis Behring Gmbh Stabilized protein preparation and process for its preparation
DE10211632A1 (en) * 2002-03-15 2003-10-09 Aventis Behring Gmbh Process for the separation of viruses from a protein solution by nanofiltration
JP2007503838A (en) 2003-09-05 2007-03-01 ジーティーシー バイオセラピューティクス， インコーポレイティド Method for producing fusion protein in milk of transgenic animals
FR2861395B1 (en) 2003-10-23 2006-02-17 Lab Francais Du Fractionnement FACTOR VIII VIRAL SECURITY WITH LOW HIGHER MULTIMER CONTENT
FR2874216B1 (en) 2004-08-16 2006-11-03 Lab Francais Du Fractionnement PROCESS FOR THE PREPARATION OF A VON WILLEBRAND FACTOR CONCENTRATE (FVW) BY CHROMATOGRAPHIC AND CONCENTRATED FVW SO LIKELY TO BE OBTAINED
EP1888208B1 (en) * 2004-10-21 2012-11-14 Statens Serum Institut A method comprising nanofiltration to obtain an mbl product safe from infectious agents
JP5022231B2 (en) 2004-12-27 2012-09-12 バクスター・インターナショナル・インコーポレイテッド Polymer-von Willebrand factor conjugate
ES2298096B1 (en) * 2008-01-08 2009-01-01 Grifols, S.A. PROCEDURE FOR OBTAINING A CONCENTRATE OF VON WILLEBRAND FACTOR OR FACTOR COMPLEX VIII / VON WILLEBRAND FACTOR AND USING THEMSELVES.
CN103739712B (en) 2008-06-24 2016-10-05 德国杰特贝林生物制品有限公司 There is the Factor IX of the Half-life in vivo of prolongation, vWF or their complex
CN102387784B (en) 2008-10-21 2014-04-02 巴克斯特国际公司 Lyophilized recombinant vwf formulations
MX2012002129A (en) 2009-08-20 2012-06-08 Baxter Int Purification of vwf for increased removal of non-lipid enveloped viruses.
US20140154233A1 (en) * 2012-12-05 2014-06-05 Csl Limited Method of purifying therapeutic proteins
AU2015274238B2 (en) 2014-06-13 2020-11-05 Csl Limited Improved production of recombinant von Willebrand factor in a bioreactor
CN104804078B (en) * 2015-05-05 2019-01-04 广东卫伦生物制药有限公司 Virus filtration method in human serum platelet cofactor Ⅰ
CN105622747A (en) * 2016-02-04 2016-06-01 江西博雅生物制药股份有限公司 vWF (von Willebrand factor) activity protection fluid
CN105622746A (en) * 2016-02-04 2016-06-01 江西博雅生物制药股份有限公司 Preparation process for extracting human von Willebrand factor from waste of cryoprecipitate extraction blood coagulation factor VIII

Also Published As

Publication number Publication date
JP2020531516A (en) 2020-11-05
WO2019038350A1 (en) 2019-02-28
CA3072003A1 (en) 2019-02-28
AU2018321131A1 (en) 2020-04-09
KR20200038309A (en) 2020-04-10
CN110997015A (en) 2020-04-10
BR112020002234A2 (en) 2020-07-28
US20200199176A1 (en) 2020-06-25
EP3672644A1 (en) 2020-07-01

Similar Documents

Publication Publication Date Title
EP3342247A4 (en) Method of enhanced timer handling for sim or usim change
IL285146A (en) Methods of purifying fc-containing proteins
DE112016002061A5 (en) Method for producing filter bellows
IL253971A0 (en) Method of purifying albumin-fusion proteins
SG10202103120UA (en) Anti-coagulation factor xi antibodies
HK1250724A1 (en) Methods for preparing modified von willebrand factor
IL263342A (en) Method for stabilizing proteins
HK1250375A1 (en) Virus filtration
HK1250625A1 (en) Truncated von willebrand factor polypeptides for treating hemophilia
EP3164150A4 (en) Modified von willebrand factor
HK1249046A1 (en) Methods of treating hepatitis b virus
IL255094A0 (en) Method for increasing the percentage of monomeric antibody fab-dsfv multimeric species
SG10202101105XA (en) Charged depth filtration of antigen-binding proteins
DK3400238T3 (en) MUTERATED BY WILLEBRAND FACTOR
IL272807A (en) Method for purifying proteins
DK3538133T3 (en) TRUNKED VON WILLEBRAND FACTOR POLYPEPTIDES FOR THE TREATMENT OF HEMOPHILIA
HK1255456A1 (en) Expression of fc-containing proteins
SG11202000695RA (en) Method for virus filtration of von willebrand factor
PT3135687T (en) Method for the preparation of immunoglobulins
GB201520964D0 (en) Filtration material and method of manufacture thereof
EP3148574A4 (en) Purified compositions of ivig and kh proteins for modulating lymphocytes and treating hepatitis b virus
GB201806736D0 (en) Method for virus purification
DK3265489T3 (en) CONNECTIONS FOR IMPROVING THE HALF TIME OF VON WILLEBRAND FACTOR
DK3286198T3 (en) COMPOUNDS FOR THE TREATMENT OF PRURITIC CONDITIONS
ZA201902183B (en) Purification process of fviii